Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00115622 · ClinicalTrials.gov registry record · Phase 3
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 304
- Enrollment target
NCT00115622 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 304 participants.
The verdict
NCT00115622, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 304 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as "hay fever", it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.
Interventions
- DRUG fluticasone furoate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00115622
The ClinicalTrials.gov registry entry for NCT00115622 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluticasone furoate is the first listed.
NCT00115622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00115622 about?
NCT00115622 is a clinical study titled "Study In Adults And Adolescents With Seasonal Allergic Rhinitis". The purpose of the study is to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of t...
What is the current status of trial NCT00115622?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 304 participants. The study started on 2004-12. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00115622?
The interventions under investigation include: fluticasone furoate (DRUG).
Who is sponsoring clinical trial NCT00115622?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.